ConductScience.org, home

Paper1976342

Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

Waller DG. Br J Clin Pharmacol, 1990. Cited by 19 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy? Papers, record 1976342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1976342

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1990
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.97
iCite
Revised in PubMed
2019-05-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Waller DGD G

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AgonistsMajor topic
Adrenergic beta-AntagonistsMajor topic
Cardiovascular DiseasesMajor topic
HemodynamicsMajor topic
Airway Resistance
Humans
Lipids

Source PubMed

References79

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12,899,509Influence of xamoterol, a partial beta 1-selective agonist, on physical performance capacity and cardiocirculatory, metabolic and hormonal parameters.Eur J Clin Pharmacol1988https://conductscience.org/library/papers/2899509PubMed
26,182,405Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists.J Cardiovasc Pharmacol1982https://conductscience.org/library/papers/6182405PubMed
32,876,788
Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.
Circ Res1986https://conductscience.org/library/papers/2876788PubMed
42,893,634An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.Br J Clin Pharmacol1987https://conductscience.org/library/papers/2893634PubMed
525,075Beta-blockers and asthma.Br Heart J1978https://conductscience.org/library/papers/25075PubMed
687,834Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade.Lancet1979https://conductscience.org/library/papers/87834PubMed
72,859,740The first dose hemodynamic responses to Visacor (ICI 141-292) in essential hypertension.Acta Med Scand Suppl1985https://conductscience.org/library/papers/2859740PubMed
83,312,931Clinical consequences of abrupt drug withdrawal.Med Toxicol Adverse Drug Exp1987https://conductscience.org/library/papers/3312931PubMed
96,125,186The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6125186PubMed
106,143,634Cardioselectivity, kinetics, hemodynamics, and metabolic effects of xamoterol.Clin Pharmacol Ther1984https://conductscience.org/library/papers/6143634PubMed
112,421,751The cardiovascular effects of xamoterol, a beta 1-adrenoceptor partial agonist, in healthy volunteers at rest.Br J Clin Pharmacol1986https://conductscience.org/library/papers/2421751PubMed
123,078,085The influence of clinical adrenoceptor antagonism on plasma lipid profiles.Trends Pharmacol Sci1988https://conductscience.org/library/papers/3078085PubMed
132,570,461Molecular characterization of the human beta 3-adrenergic receptor.Science1989https://conductscience.org/library/papers/2570461PubMed
146,117,303Influence of intrinsic sympathomimetic activity of beta-adrenoceptor blockers on the heart rate and blood pressure responses to graded exercise.Br J Clin Pharmacol1981https://conductscience.org/library/papers/6117303PubMed
152,872,055Effects of xamoterol a new beta-adrenoceptor partial agonist, in patients with angina pectoris.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/2872055PubMed
165,787,671Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man.Br J Pharmacol1969https://conductscience.org/library/papers/5787671PubMed
176,118,172Once daily beta-adrenoceptor blockade in hypertension: an ambulatory assessment.Br J Clin Pharmacol1981https://conductscience.org/library/papers/6118172PubMed
184,618,580Cardiovascular studies of 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a new potent beta-adrenergic blocking agent.Jpn J Pharmacol1974https://conductscience.org/library/papers/4618580PubMed
192,866,062
Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
Clin Sci (Lond)1985https://conductscience.org/library/papers/2866062PubMed
202,878,742Hemodynamic effects of the beta 1-adrenoceptor partial agonist xamoterol in relation to plasma norepinephrine levels during exercise in patients with left ventricular dysfunction.Circulation1987https://conductscience.org/library/papers/2878742PubMed

See all 79 references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
8,693,438Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.Thorax1996https://conductscience.org/library/papers/8693438PubMed
8,658,370Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.Thorax1996https://conductscience.org/library/papers/8658370PubMed
8,329,290Effects of dilevalol (R,R-labetalol) compared with nifedipine on heart rate, blood pressure and muscle blood flow at rest and on exercise in hypertensive patients.Br J Clin Pharmacol1993https://conductscience.org/library/papers/8329290PubMed
7,701,450Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone.Thorax1995https://conductscience.org/library/papers/7701450PubMed
1,867,956Clinical pharmacology through the looking glass: reflections on the racemate vs enantiomer debate.Br J Clin Pharmacol1991https://conductscience.org/library/papers/1867956PubMed
1,687,999Cardiac beta 2-adrenoceptors and the inotropic response to exercise in man.Clin Auton Res1991https://conductscience.org/library/papers/1687999PubMed
1,685,667The effects of selective beta-adrenoceptor antagonists and partial agonist activity on renal function during exercise in normal subjects and those with moderate renal impairment.Br J Clin Pharmacol1991https://conductscience.org/library/papers/1685667PubMed
1,678,960The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes.Cardiovasc Drugs Ther1991https://conductscience.org/library/papers/1678960PubMed
1,541,316Differential cardiovascular effects of propranolol, atenolol, and pindolol measured by impedance cardiography.Eur J Clin Pharmacol1992https://conductscience.org/library/papers/1541316PubMed
1,349,493Evaluation of in vivo partial beta 1/beta 2-agonist activity: a dose-ranging study with carteolol.Br J Clin Pharmacol1992https://conductscience.org/library/papers/1349493PubMed
1,333,781Selectivity of antagonist and partial agonist activity of celiprolol in normal subjects.Br J Clin Pharmacol1992https://conductscience.org/library/papers/1333781PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1976342

GET https://conductscience.org/api/papers/v1/1976342/references?page=2